Subthreshold Laser Therapy for Diabetic Macular Edema: Metabolic and Safety Issues

201343 citationsReview

Authors

Stela Vujosevic · University of Padua

Ferdinando Martini

Edoardo Midena · University of Padua

Abstract

MPL is a new, promising treatment option in DME, with both infrared and yellow wavelengths using the less aggressive duty cycle (5%) and fixed power parameters. It appears to be safe from morphologic and functional point of view in mild center involving DME.

Topics & Keywords

Retinal Diseases and Treatments Glaucoma and retinal disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Current Medicinal Chemistry

Volume 20, Issue 26, pp. 3267-3271

DOI: 10.2174/09298673113209990030

Field-Weighted Citation Impact: 2.51